Drug Shortage Report for KETALAR
| Report ID | 131448 |
| Drug Identification Number | 00224405 |
| Brand name | KETALAR |
| Common or Proper name | KETALAR |
| Company Name | ERFA CANADA 2012 INC |
| Market Status | MARKETED |
| Active Ingredient(s) | KETAMINE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10ML VIAL |
| ATC code | N01AX |
| ATC description | ANESTHETICS, GENERAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-01-01 |
| Actual start date | 2021-01-04 |
| Estimated end date | 2021-01-29 |
| Actual end date | 2021-01-29 |
| Shortage status | Resolved |
| Updated date | 2021-02-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 NOTRE DAME ST. WEST MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-02-01 | French | Compare |
| v4 | 2021-02-01 | English | Compare |
| v3 | 2021-01-12 | French | Compare |
| v2 | 2021-01-12 | English | Compare |
| v1 | 2021-01-12 | English | Compare |
Showing 1 to 5 of 5